Biotech Adela Announces Clinical Validation Results for Head & Neck Cancer MRD Test Simultaneously Published in Annals of Oncology and Presented at ESMO 2024 September 15, 2024
Biotech ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress September 14, 2024
Biotech City of Hope and Biopharmaceutical Research Company announce first patient has received BRC-001, a first-in-class cannabinoid therapeutic, in a clinical trial investigating supportive care in breast cancer September 13, 2024
Biotech FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer January 23, 2024
Biotech Vesper Bio awarded grant by The Michael J. Fox Foundation to assess sortilin inhibitors in the treatment of Parkinson’s disease January 23, 2024
Biotech Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy January 23, 2024
Biotech Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B January 23, 2024